AXGN insider trading
NasdaqCM HealthcareAxogen, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Axogen, Inc.
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
Company website: www.axogeninc.com
AXGN insider activity at a glance
FilingIQ has scored 793 insider transactions for AXGN since Sep 30, 2014. The most recent filing in our index is dated May 8, 2026.
Across the full history, 40 open-market purchases
and 160 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on AXGN insider trades is 62.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest AXGN Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading AXGN
Frequently asked
- How many insider trades does FilingIQ track for AXGN?
- FilingIQ tracks 793 Form 4 insider transactions for AXGN (Axogen, Inc.), covering filings from Sep 30, 2014 onwards. 50 of those were filed in the last 90 days.
- Are AXGN insiders net buyers or net sellers?
- Across the full Form 4 history for AXGN, 40 transactions (5%) were open-market purchases and 160 (20%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AXGN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is AXGN in?
- Axogen, Inc. (AXGN) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.77B.
Methodology & sources
Every AXGN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.